동물용 신속 검사 시장 : 제품 유형, 대상 동물, 기술, 용도, 최종사용자, 유통 채널별 - 시장 예측(2026-2032년)

The Veterinary Rapid Test Market is projected to grow by USD 3.90 billion at a CAGR of 13.31% by 2032.

Veterinary rapid testing is moving from a convenience tool to a frontline diagnostic capability for animal health, food safety, and zoonotic disease surveillance. The category includes lateral flow immunoassays, rapid ELISA formats, point-of-care molecular assays, and compact analyzers used to detect pathogens, antibodies, hormones, toxins, and biomarkers in companion animals, livestock, poultry, equine care, and aquaculture.

Demand is supported by measurable public health and agricultural pressures. The World Organisation for Animal Health reports that around 60% of human infectious diseases are zoonotic, while WHO, FAO, and WOAH continue to promote One Health surveillance to connect animal, human, and environmental health systems. In this setting, rapid veterinary diagnostics help veterinarians shorten time to treatment, support herd-level biosecurity, reduce avoidable antimicrobial use, strengthen vaccination and screening programs, and protect animal-derived food supply chains.

Transformative Shifts in the Veterinary Rapid Test Landscape

The veterinary rapid test landscape is being reshaped by the shift from centralized, laboratory-only workflows toward decentralized point-of-care testing in clinics, farms, shelters, border inspection sites, and food production settings. This transformation is most visible in infectious disease screening, where fast decision-making is essential for conditions such as canine parvovirus, feline leukemia virus, avian influenza, bovine respiratory disease, brucellosis, mastitis, rabies surveillance, and African swine fever monitoring.

Another structural shift is the convergence of diagnostics, digital reporting, and preventive animal health programs. Veterinarians and producers increasingly require tests that are easy to administer, deliver actionable results in minutes, and integrate with electronic medical records or farm management systems. Regulatory expectations for traceability, residue control, antimicrobial resistance monitoring, and disease notification are also strengthening the role of validated rapid tests across the veterinary value chain.

Cumulative Impact of Artificial Intelligence on Veterinary Rapid Testing

Artificial intelligence is expanding the value of veterinary rapid testing by improving result interpretation, workflow automation, and disease surveillance. AI-enabled image analysis can reduce subjectivity in lateral flow test readings, particularly for weak-positive or borderline results, while algorithmic decision support can combine test outcomes with clinical signs, vaccination history, geography, seasonality, species, and herd or flock data.

The cumulative impact is broader than individual test performance. When rapid test data are digitized, AI can help identify outbreak clusters, assess disease risk, optimize inventory at clinics and farms, support quality control, and strengthen antimicrobial stewardship. These benefits are especially relevant as veterinary systems address emerging zoonoses, high-density livestock production, companion animal wellness programs, and the need for faster evidence-based treatment decisions.

Key Regional Insights Across Veterinary Rapid Test Markets

Asia-Pacific is a high-priority region because of its large livestock population, rising pet care spending, intensive poultry and swine production, and recurring pressure from transboundary animal diseases. China and India represent substantial demand pools for livestock and companion animal diagnostics, while Japan, South Korea, and Australia emphasize quality-controlled veterinary care, food safety, biosecurity, and advanced point-of-care technologies. ASEAN markets are strengthening rapid testing capacity as poultry, swine, aquaculture, and dairy production become more integrated with export standards and regional disease surveillance programs.

North America remains a mature and innovation-led region, supported by extensive companion animal ownership, advanced veterinary clinics, producer-led herd health programs, and regulatory attention from agencies such as the USDA, FDA, and CFIA. Europe benefits from strong animal welfare regulation, EU surveillance frameworks, food chain controls, and veterinary antimicrobial stewardship initiatives. Latin America, led by Brazil and Mexico, is shaped by livestock export competitiveness, companion animal care expansion, and disease control requirements for beef, poultry, pork, and dairy value chains. The Middle East shows expanding need for portable and field-ready diagnostics as governments address food security, import inspection, equine health, camel health, and livestock mobility. Africa demonstrates increasing relevance for rapid veterinary diagnostics due to endemic and transboundary disease monitoring, pastoral livestock systems, and the need for practical tools in resource-variable field environments.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is gaining relevance for veterinary rapid tests as regional governments invest in livestock productivity, aquaculture health, and surveillance for diseases affecting poultry, swine, dairy animals, and farmed fish. The GCC market is shaped by food security strategies, import controls, equine and camel health programs, and the need for reliable testing in hot, mobile, and distributed care environments where rapid decisions can reduce disease spread and support animal movement controls.

The European Union provides one of the most structured regulatory environments for veterinary diagnostics, with strong emphasis on animal welfare, food chain safety, disease notification, and antimicrobial resistance reduction. BRICS countries represent a broad demand base because they combine large animal populations, fast-growing protein consumption, livestock intensification, and expanding veterinary infrastructure. G7 markets are generally characterized by premium companion animal care, high diagnostic adoption, established laboratory networks, and faster uptake of digital point-of-care systems, while NATO countries benefit from coordinated biosecurity awareness, especially around zoonotic risk, livestock disease preparedness, border health security, and resilience of critical food supply systems.

Key Country Insights in Major Veterinary Rapid Test Markets

The United States leads in veterinary rapid test adoption through a strong companion animal clinic network, advanced livestock production systems, and broad use of point-of-care diagnostics across pet care, dairy, swine, poultry, and equine health. Canada emphasizes animal health surveillance, food safety, antimicrobial stewardship, and distributed testing across large geographies, while Mexico is expanding demand through companion animal care, livestock disease management, and cross-border food supply integration. Brazil is a major opportunity due to its global role in beef, poultry, and pork exports, which increases the need for rapid screening, herd health tools, residue control support, and disease surveillance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support demand through established veterinary services, high pet ownership, livestock traceability, animal welfare standards, and antimicrobial stewardship. Russia's large geography and livestock base create need for field-deployable testing to support regional disease monitoring and farm-level decision-making. China and India are central to Asia-Pacific development because of their large animal populations, expanding protein consumption, and increasing veterinary service penetration, while Japan and South Korea favor high-quality diagnostic platforms for companion animals, livestock health, and food safety. Australia's biosecurity priorities, disease-free status protection, and export-oriented livestock sector reinforce the value of validated rapid tests across farms, clinics, and surveillance programs.

Actionable Recommendations for Veterinary Rapid Test Leaders

Industry leaders should prioritize validated, easy-to-use rapid tests that deliver reliable performance in real-world veterinary settings, including clinics, farms, shelters, border control points, and field surveillance programs. Product portfolios should address high-volume diseases in companion animals while also supporting livestock, poultry, equine, and aquaculture biosecurity needs through ruggedized kits, clear interpretation tools, temperature-stable formats, and practical sample collection workflows.

Commercial strategy should combine distributor depth with clinician education, digital result capture, quality assurance, and technical support. Companies that integrate rapid tests with tele-veterinary workflows, herd management software, laboratory information systems, and AI-assisted analytics will be better positioned to demonstrate measurable value in faster treatment, reduced production losses, responsible antimicrobial use, stronger compliance, and outbreak preparedness.

Research Methodology for Veterinary Rapid Test Analysis

This executive summary is developed through secondary research and structured market analysis using verified public sources, regulatory references, veterinary health publications, scientific literature, industry filings, and institutional data from organizations such as WOAH, WHO, FAO, CDC, USDA, FDA, EFSA, EMA, and national veterinary authorities. The research framework evaluates disease burden, animal population trends, diagnostic adoption, regulatory requirements, technology innovation, end-user workflows, and commercial distribution patterns.

Insights are triangulated across regional demand indicators, product category trends, end-user behavior, public health priorities, biosecurity programs, and documented animal disease surveillance needs. The methodology emphasizes data reliability, source consistency, and practical relevance for veterinary rapid test manufacturers, distributors, investors, veterinarians, producers, and animal health decision-makers, without relying on unverified projections or speculative sizing assumptions.

Conclusion: Veterinary Rapid Tests as a Core Animal Health Capability

The veterinary rapid test market is becoming a strategic pillar of modern animal health because it supports faster diagnosis, earlier intervention, stronger biosecurity, and more responsible treatment decisions. As One Health priorities intensify, rapid tests are increasingly important for connecting clinical care, livestock productivity, food safety, antimicrobial stewardship, and zoonotic disease surveillance.

Future competitiveness will depend on accuracy, usability, affordability, field robustness, regulatory alignment, and digital integration. Organizations that combine validated assays with AI-enabled interpretation, regional disease expertise, practical training, and scalable distribution models will be well positioned to serve demand across companion animal clinics, livestock systems, aquaculture operations, border inspection programs, and public health surveillance networks.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Rapid Test Market, by Product Type

• 7.1. Enzyme Linked Immunosorbent Assay
  • 7.1.1. Competitive
  • 7.1.2. Direct
  • 7.1.3. Indirect
  • 7.1.4. Sandwich
• 7.2. Lateral Flow Immunoassay
  • 7.2.1. Competitive
  • 7.2.2. Multiplex
  • 7.2.3. Sandwich

8. Veterinary Rapid Test Market, by Animal Type

• 8.1. Companion Animals
  • 8.1.1. Cats
  • 8.1.2. Dogs
• 8.2. Livestock
  • 8.2.1. Cattle
  • 8.2.2. Poultry
  • 8.2.3. Swine

9. Veterinary Rapid Test Market, by Technology

• 9.1. Colorimetric Techniques
• 9.2. Immunoassay
  • 9.2.1. Chemiluminescence
  • 9.2.2. Fluorescence
  • 9.2.3. Lateral Flow
• 9.3. Molecular Diagnostics
  • 9.3.1. Isothermal Amplification
    • 9.3.1.1. LAMP
    • 9.3.1.2. RPA
  • 9.3.2. PCR
    • 9.3.2.1. Digital PCR
    • 9.3.2.2. qPCR

10. Veterinary Rapid Test Market, by Application

• 10.1. Genetic Tests
  • 10.1.1. Mutation Detection
  • 10.1.2. Species Identification
• 10.2. Hormonal Assays
  • 10.2.1. Reproductive
  • 10.2.2. Thyroid
• 10.3. Infectious Diseases
  • 10.3.1. Bacterial
  • 10.3.2. Fungal
  • 10.3.3. Viral
• 10.4. Parasitic Infections
  • 10.4.1. Ectoparasite
  • 10.4.2. Endoparasite

11. Veterinary Rapid Test Market, by End User

• 11.1. Clinical Laboratories
• 11.2. Pharmacies
• 11.3. Research Institutes
• 11.4. Veterinary Hospitals

12. Veterinary Rapid Test Market, by Distribution Channel

• 12.1. Direct Sales
• 12.2. eCommerce
• 12.3. Retail Distributors

13. Veterinary Rapid Test Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Veterinary Rapid Test Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Veterinary Rapid Test Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Biogal Galed Laboratories Ltd.
• 17.2. BioNote, Inc.
• 17.3. Biopanda Reagents Ltd.
• 17.4. Biosynex S.A.
• 17.5. Boster Biological Technology Co., Ltd.
• 17.6. Coris BioConcept SPRL
• 17.7. DiaSys Diagnostic Systems GmbH
• 17.8. Fassisi GmbH
• 17.9. Hangzhou Genesea Biotechnology Co., Ltd.
• 17.10. Heska Corporation
• 17.11. IDEXX Laboratories, Inc.
• 17.12. IDvet SAS
• 17.13. Ingenasa S.A.
• 17.14. MEGACOR Diagnostik GmbH
• 17.15. Neogen Corporation
• 17.16. PRIMA Lab S.A.
• 17.17. Prometheus Bio Inc.
• 17.18. Ring Biotechnology Co., Ltd.
• 17.19. SWISSAVANS AG
• 17.20. Thermo Fisher Scientific Inc.
• 17.21. Tianjin Era Biology Technology Co., Ltd.
• 17.22. Virbac S.A
• 17.23. VITASSAY HEALTHCARE S.L.
• 17.24. Woodley Equipment Company Ltd.
• 17.25. Zoetis Inc.